Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
OBJECTIVE: Learning robust representations from scarce labeled bio-electrical time-series data remai...
Lateralization is a hallmark of brain organization, yet the structural basis underlying this phenome...
PURPOSE: To examine the readability and linguistic characteristics of Alzheimer's disease and relate...
PURPOSE: Antibody-drug conjugates (ADC) targeting trophoblast cell surface antigen 2 (TROP-2) and cM...
Kidney fibrosis, characterized by excessive extracellular matrix deposition and progressive renal ti...
Brain imaging genetics generally combines genotype data with brain structure and functional measures...
OBJECTIVE: This study aims to support early diagnosis of Alzheimer's disease and detection of amyloi...
The diagnosis of Alzheimer's disease (AD) has progressively depended on sophisticated neuroimaging m...
Polyproline II (PPII) helices are extended left-handed secondary structures increasingly recognized ...
BackgroundMild cognitive impairment is a prodromal stage of dementia, and early identification is cr...
This study introduces a deep learning framework for the inferential exploration of latent representa...
Treatment resistance (TR) in major depressive disorder (MDD) affects a substantial minority of patie...
Mild Cognitive Impairment (MCI) involves cognitive decline beyond age-expected norms without impairi...
BACKGROUND: Hip fractures are a major global health issue with high mortality and morbidity, especia...
Loneliness and social isolation are important psychosocial concerns in dementia care, but they are d...
Alzheimer's Disease (AD) is a degenerative neurological condition characterized by memory loss, cogn...
Delirium is a prevalent neuropsychiatric syndrome affecting up to 50% of hospitalized elderly patien...
Advances in voice recognition and artificial intelligence (AI) could soon yield digital conversation...
Facial analysis is increasingly being explored as a source of scalable behavioral signals relevant t...
INTRODUCTION: Identifying disease-modifying drug targets is crucial for developing effective Alzheim...
INTRODUCTION: Alzheimer's Disease (AD) affects more than 57 million people, yet drug development fac...